Article
Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?
Arteriosclerosis, thrombosis, and vascular biology - 1 Sept 2001
Mackness B, Davies G K, Turkie W, Lee E, Roberts D H, Hill E, Roberts C, Durrington P N, Mackness M I
Abstract excerpt
Human serum paraoxonase (PON1) hydrolyzes oxidized lipids in low density lipoprotein (LDL) and could therefore retard the development of atherosclerosis. In keeping with this hypothesis, several case-control studies have shown a relationship between the presence of coronary heart disease (CHD) and polymorphisms at amino acid positions 55 and 192 of PON1, which we associated with a decreased capacity of PON1 to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
